Yue Jiang

Title: Yue Jiang: Innovator in Immunotherapy

Introduction

Yue Jiang is a prominent inventor based in Seattle, WA (US), known for her significant contributions to the field of immunotherapy. With a total of 4 patents, she has made remarkable strides in developing innovative treatments that harness the power of the immune system.

Latest Patents

Yue Jiang's latest patents include groundbreaking work on antibodies and chimeric antigen receptors specific for receptor tyrosine kinase-like orphan receptor 1 (ROR1). This patent provides receptor tyrosine kinase-like orphan receptor 1 (ROR1)-binding molecules, particularly human antibodies specific for ROR1, including antibody fragments. The disclosure further relates to recombinant receptors, including chimeric antigen receptors (CARs) that contain such antibodies or fragments, and polynucleotides that encode the antibodies, antigen-binding fragments, or receptors specific for ROR1. Additionally, her work includes methods and combinations for treatment and T cell modulation, focusing on immunotherapies such as adoptive cell therapy and T cell therapy, involving immunomodulatory compounds.

Career Highlights

Throughout her career, Yue Jiang has worked with notable companies in the biotechnology sector, including Juno Therapeutics GmbH and Editas Medicine, Inc. Her expertise in immunotherapy has positioned her as a key player in the development of innovative treatments that aim to improve patient outcomes.

Collaborations

Yue Jiang has collaborated with esteemed colleagues, including Stephen Jacob Goldfless and Brian J Belmont. These partnerships have further enhanced her research and development efforts in the field of immunotherapy.

Conclusion

Yue Jiang's contributions to immunotherapy through her patents and collaborations highlight her as a leading inventor in the field. Her work continues to pave the way for advancements in cancer treatment and immune system modulation.